Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Management Change, Fate Therapeutics CEO Exits

Fate Therapeutics’ (San Diego-based developer of stem cell therapies) CEO Paul Grayson is leaving.

The new company wasn’t named and Fate didn’t say who will replace Grayson.

  • Fate still lists John Mendlein as executive chairman. Grayson, who was previously a managing director with Sanderling Ventures, led Fate for 3 years.